Company Filing History:
Years Active: 2001
Title: Innovations of Kenneth Letwin in Neural Receptor Tyrosine Kinase
Introduction
Kenneth Letwin is an accomplished inventor based in Willowdale, CA. He has made significant contributions to the field of neuroscience through his innovative work on receptor tyrosine kinases. His research focuses on the mechanisms of neural signaling and the potential therapeutic applications of these proteins.
Latest Patents
Kenneth Letwin holds a patent for a novel receptor tyrosine kinase protein and its isoforms, which are expressed in migrating axons. The patent describes nucleic acid molecules encoding these novel protein isoforms and parts thereof. Additionally, the invention outlines methods for identifying substances that can bind to the receptor protein, as well as screening for agonists or antagonists of the binding. Diagnostic and therapeutic methods utilizing the protein and nucleic acid molecules are also included in the patent.
Career Highlights
Kenneth Letwin is associated with Mount Sinai Hospital Corporation, where he continues to advance his research in the field of neuroscience. His work has the potential to impact various therapeutic approaches for neurological disorders.
Collaborations
Kenneth has collaborated with notable scientists such as Anthony J Pawson and Mark Henkemeyer, contributing to the advancement of knowledge in receptor tyrosine kinases.
Conclusion
Kenneth Letwin's innovative work in the field of receptor tyrosine kinases showcases his dedication to advancing neuroscience. His contributions have the potential to lead to significant breakthroughs in diagnostic and therapeutic methods.